AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32215577 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic Ablative Radiation (SABR)
Number of subjects: 54
Study 32215577 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 54
Study 34422085 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ESWT), two times/week for 4 weeks
Number of subjects: 30
Study 34422085 — intervention group
Group type: COMPARATOR
Intervention: Manual Lymphatic Drainage (MLD), two times/week for 4 weeks
Number of subjects: 30
Study 34921022 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 430
Study 34921022 — intervention group
Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 430
Study 35577898 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention with a reduced calorie diet (1200–1800 kcal/d) and increased physical activity (300 min/wk)
Number of subjects: 156
Study 35577898 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower sleep efficiency, higher wake after sleep onset (WASO), more awakenings, and higher sleep onset latency (SOL)
Number of subjects: 156
Study 35577898 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower sleep efficiency, more awakenings, and higher SOL
Number of subjects: 156
Study 35577898 — intervention group
Group type: EXPERIMENTAL
Intervention: Later waketime, longer time in bed, longer sleep duration, higher WASO, more awakenings, and higher SOL
Number of subjects: 156
Study 33513820 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxian® (probiotic supplement) for 60 days
Number of subjects: 32
Study 33323210 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART-CR/SP (smartphone-based cardiac rehabilitation via WeChat)
Number of subjects: 312
Study 33323210 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard outpatient cardiology follow-up without formal cardiac rehabilitation)
Number of subjects: 312
Study 36306974 — intervention group
Group type: EXPERIMENTAL
Intervention: CureSight treatment (90 minutes/day, 5 days/week for 16 weeks)
Number of subjects: 103
Study 36306974 — intervention group
Group type: COMPARATOR
Intervention: Patching (2 hours/day, 7 days/week for 16 weeks)
Number of subjects: 103
Study 33506629 — intervention group
Group type: COMPARATOR
Intervention: Single Pass (SP) emission
Number of subjects: 63
Study 33506629 — intervention group
Group type: EXPERIMENTAL
Intervention: MultiPass emission (MoveoPL)
Number of subjects: 63
Study 33272279 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth solution using the 24alife app with a compliance rate of 94.1%
Number of subjects: 17
Study 33272279 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth solution using the 24alife app
Number of subjects: 17
Study 35440229 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal Exposure (IE)
Number of subjects: 47
Study 35440229 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal Exposure preceded by a brief food exposure (IE + Food)
Number of subjects: 47
Study 35440229 — intervention group
Group type: COMPARATOR
Intervention: Assessment Control
Number of subjects: 47
Study 33169186 — intervention group
Group type: EXPERIMENTAL
Intervention: HLX02
Number of subjects: 109
Study 33169186 — intervention group
Group type: COMPARATOR
Intervention: CN-trastuzumab
Number of subjects: 109
Study 33169186 — intervention group
Group type: COMPARATOR
Intervention: EU-trastuzumab
Number of subjects: 109
Study 34923514 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcorneal electrical stimulation (TES), 30 minutes/week for 6 months
Number of subjects: 15
Study 33627641 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensembled deep learning model
Number of subjects: 0
Study 33627641 — intervention group
Group type: COMPARATOR
Intervention: Human experts
Number of subjects: 0
Study 33627641 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis based on smartphone photos
Number of subjects: 0
Study 33627641 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis based on video sequences by the model
Number of subjects: 0
Study 32483634 — intervention group
Group type: EXPERIMENTAL
Intervention: PREP-C assessment
Number of subjects: 100
Study 32483634 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 36431167 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical intervention (SuperCalm)
Number of subjects: 0
Study 36431167 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (InnerCalm and SuperCalm)
Number of subjects: 0
Study 36431167 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral intervention (InnerCalm)
Number of subjects: 0
Study 32620260 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia without tourniquet
Number of subjects: 413
Study 32620260 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with tourniquet
Number of subjects: 413
Study 32620260 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia without tourniquet
Number of subjects: 413
Study 32620260 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia with tourniquet
Number of subjects: 413
Study 32620260 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 413
Study 32620260 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 413
Study 32620260 — intervention group
Group type: EXPERIMENTAL
Intervention: Without tourniquet
Number of subjects: 413
Study 32620260 — intervention group
Group type: EXPERIMENTAL
Intervention: With tourniquet
Number of subjects: 413
Study 32620260 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet use
Number of subjects: 413
Study 32024950 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab 16 mg/kg intravenously on intense dosing schedule
Number of subjects: 123
Study 32024950 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab 16 mg/kg intravenously on intermediate dosing schedule
Number of subjects: 123
Study 32024950 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab 16 mg/kg intravenously on short dosing schedule
Number of subjects: 123
Study 33146774 — intervention group
Group type: EXPERIMENTAL
Intervention: Strip meniscometry
Number of subjects: 201
Study 33146774 — intervention group
Group type: EXPERIMENTAL
Intervention: Schirmer's 1 test
Number of subjects: 201
Study 33146774 — intervention group
Group type: EXPERIMENTAL
Intervention: Jones test
Number of subjects: 201
Study 33146774 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT meniscometry
Number of subjects: 201
Study 33146774 — intervention group
Group type: EXPERIMENTAL
Intervention: OSDI questionnaire
Number of subjects: 201
Study 33257632 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC treatment in Shandong Province for six months
Number of subjects: 2353
Study 33257632 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC treatment in Jilin Province for six months
Number of subjects: 2353
Study 33257632 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both regimens
Number of subjects: 2353
Study 36445907 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) injection
Number of subjects: 30
Study 36445907 — intervention group
Group type: COMPARATOR
Intervention: Dry Needling (DN)
Number of subjects: 30
Study 32492186 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sentinel node navigation surgery (LSNNS)
Number of subjects: 580
Study 32492186 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic standard gastrectomy (LSG)
Number of subjects: 580
Study 35086508 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention including community health worker education, distribution of birth kits with misoprostol, and transport subsidy.
Number of subjects: 9565
Study 35086508 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-intervention period).
Number of subjects: 9565
Study 35086508 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes related to antenatal and postpartum care and postpartum hemorrhage.
Number of subjects: 9565
Study 33518615 — intervention group
Group type: EXPERIMENTAL
Intervention: Mealtime faster aspart
Number of subjects: 66
Study 33518615 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-meal faster aspart
Number of subjects: 66
Study 33518615 — intervention group
Group type: COMPARATOR
Intervention: Insulin aspart (IAsp)
Number of subjects: 66
Study 36474739 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal penile nerve block (DPNB) alone with 4 mg/kg plain lidocaine
Number of subjects: 72
Study 36474739 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine-prilocaine cream (LPC) applied to the phallus 1 hour before DPNB
Number of subjects: 72
Study 33461398 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual monitoring clinic (VMC)
Number of subjects: 192
Study 33461398 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 192
Study 33908687 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotadutide 100 μg
Number of subjects: 93
Study 33908687 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotadutide 200 μg
Number of subjects: 93
Study 33908687 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotadutide 300 μg
Number of subjects: 93
Study 33908687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 34740705 — intervention group
Group type: EXPERIMENTAL
Intervention: EDP-305 2.5 mg
Number of subjects: 134
Study 34740705 — intervention group
Group type: EXPERIMENTAL
Intervention: EDP-305 1 mg
Number of subjects: 134
Study 34740705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 34507557 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO Safe Childbirth Checklist (WHO-SCC) implemented in intervention facilities with training and supportive supervision
Number of subjects: 2530
Study 34507557 — intervention group
Group type: COMPARATOR
Intervention: Standard of care in control group
Number of subjects: 2530
Study 34507557 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct observations of healthcare providers' adherence to evidence best practices
Number of subjects: 2530
Study 35227405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification for Interpretation (CBM‐I)
Number of subjects: 31
Study 35227405 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 31
Study 32005090 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistically significant findings (P<.05) reported across 44 trials
Number of subjects: 62
Study 32005090 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistically significant results with FPR greater than 5%
Number of subjects: 62
Study 32005090 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistically significant results with FPR greater than 50%
Number of subjects: 62
Study 32005090 — intervention group
Group type: EXPERIMENTAL
Intervention: Changing prior probability from skeptical to optimistic
Number of subjects: 62
Study 33823377 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic dose of pyridoxine (pyridoxine group, 46 of 105, 44%)
Number of subjects: 105
Study 33823377 — intervention group
Group type: COMPARATOR
Intervention: Homeopathic dose of pyridoxine (placebo, 59 of 105, 56%)
Number of subjects: 105
Study 32476164 — intervention group
Group type: EXPERIMENTAL
Intervention: Group intervention (n = 40); eight weekly 1.5-hour sessions
Number of subjects: 71
Study 32476164 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help (GSH) intervention (n = 31); self-study with eight weekly 20-minute phone calls
Number of subjects: 71
Study 36334113 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery rescripting (ImRs)
Number of subjects: 100
Study 36334113 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control (NIC)
Number of subjects: 100
Study 33675398 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraffin bath + splint + exercise
Number of subjects: 51
Study 33675398 — intervention group
Group type: COMPARATOR
Intervention: Splint + exercise therapy
Number of subjects: 51
Study 32556371 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a-tDCS) 1 mA for 20 min over the primary motor cortex (M1) for 5 consecutive days
Number of subjects: 32
Study 32556371 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (tDCS device turned off after 30 s)
Number of subjects: 32
Study 35979930 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartiva intervention
Number of subjects: 0
Study 35979930 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative scenario 1 (eliminating failures based solely upon radiographs findings)
Number of subjects: 0
Study 35979930 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative scenario 2 (considering only major surgical revision as a failure)
Number of subjects: 0
Study 35979930 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative scenario 3 (using VAS pain threshold of <30 as success criterion)
Number of subjects: 0
Study 34620621 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ertugliflozin
Number of subjects: 1776
Study 34620621 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg ertugliflozin
Number of subjects: 1776
Study 34620621 — intervention group
Group type: EXPERIMENTAL
Intervention: ertugliflozin
Number of subjects: 1776
Study 32784372 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy drink (140 mg of caffeine)
Number of subjects: 17
Study 32784372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 32784372 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy drink
Number of subjects: 17
Study 36523503 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US) guidance
Number of subjects: 19
Study 36523503 — intervention group
Group type: COMPARATOR
Intervention: Electrical stimulation (E-stim) guidance
Number of subjects: 19
Study 35419064 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole plus Topiramate (Group 1, n = 15)
Number of subjects: 29
Study 35419064 — intervention group
Group type: COMPARATOR
Intervention: Aripiprazole (Group 2, n = 14)
Number of subjects: 29
Study 35419064 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 29
Study 33835886 — intervention group
Group type: EXPERIMENTAL
Intervention: Itolizumab (Arm-A)
Number of subjects: 31
Study 33835886 — intervention group
Group type: COMPARATOR
Intervention: Best Supportive Care (Arm-B)
Number of subjects: 31
Study 32035361 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecc-BFR
Number of subjects: 36
Study 32035361 — intervention group
Group type: EXPERIMENTAL
Intervention: Con-BFR
Number of subjects: 36
Study 32035361 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 36015021 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial valves (EBVs) implantation
Number of subjects: 35
Study 33029934 — intervention group
Group type: EXPERIMENTAL
Intervention: Mevidalen (LY3154207) 25-200 mg (SAD study)
Number of subjects: 0
Study 33029934 — intervention group
Group type: EXPERIMENTAL
Intervention: Mevidalen (LY3154207) 15-150 mg once-daily for 14 days (MAD study)
Number of subjects: 0
Study 33029934 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33849723 — intervention group
Group type: EXPERIMENTAL
Intervention: EuTCV (Vi-CRM197)
Number of subjects: 75
Study 33849723 — intervention group
Group type: COMPARATOR
Intervention: Typbar-TCV® (WHO prequalified vaccine)
Number of subjects: 75
Study 33849723 — intervention group
Group type: COMPARATOR
Intervention: Typhim Vi® (Vi polysaccharide vaccine)
Number of subjects: 75
Study 33849723 — intervention group
Group type: EXPERIMENTAL
Intervention: EuTCV and Typbar-TCV®
Number of subjects: 75
Study 33849723 — intervention group
Group type: COMPARATOR
Intervention: Typhim Vi®
Number of subjects: 75
Study 33849723 — intervention group
Group type: EXPERIMENTAL
Intervention: EuTCV
Number of subjects: 75
Study 35396071 — intervention group
Group type: EXPERIMENTAL
Intervention: Active taVNS
Number of subjects: 15
Study 35396071 — intervention group
Group type: COMPARATOR
Intervention: Sham taVNS
Number of subjects: 15
Study 35396071 — intervention group
Group type: EXPERIMENTAL
Intervention: taVNS current ≥2.5 mA (subanalysis of 8 participants)
Number of subjects: 15
Study 32527270 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced primary care plus contextually-tailored health coaching
Number of subjects: 721
Study 32527270 — intervention group
Group type: COMPARATOR
Intervention: Enhanced primary care
Number of subjects: 721
Study 34618979 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy-load power-oriented resistance training (HL-PT, 80% 1-RM)
Number of subjects: 45
Study 34618979 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-load power-oriented resistance training (LL-PT, 40% 1-RM)
Number of subjects: 45
Study 34618979 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HL-PT and LL-PT
Number of subjects: 45
Study 34618979 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-load power-oriented resistance training (LL-PT)
Number of subjects: 45
Study 34618979 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy-load power-oriented resistance training (HL-PT)
Number of subjects: 45
Study 33885395 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered toothbrush
Number of subjects: 0
Study 33885395 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 0
Study 33289785 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT on Health program plus weekly phone coaching
Number of subjects: 79
Study 33289785 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 79
Study 32028385 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive patients' education program (IEP)
Number of subjects: 180
Study 32028385 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care only)
Number of subjects: 180
Study 35339761 — intervention group
Group type: EXPERIMENTAL
Intervention: MNmask v1
Number of subjects: 38
Study 35339761 — intervention group
Group type: EXPERIMENTAL
Intervention: MNmask v2
Number of subjects: 38
Study 32979515 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote physical activity intervention (RGV)
Number of subjects: 100
Study 32979515 — intervention group
Group type: COMPARATOR
Intervention: Usual care enhanced with caregiver support (EUC)
Number of subjects: 100
Study 35834180 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonalcoholic beer (0.0% v/v)
Number of subjects: 22
Study 35834180 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beer (5.2% v/v)
Number of subjects: 22
Study 36028881 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursed lip breathing exercise and inhaler training
Number of subjects: 67
Study 36028881 — intervention group
Group type: COMPARATOR
Intervention: Inhaler training only
Number of subjects: 67
Study 32998761 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooled dialysate (temperature 35 °C)
Number of subjects: 90
Study 32998761 — intervention group
Group type: COMPARATOR
Intervention: Standard care (dialysate temperature 36.5 °C)
Number of subjects: 90
Study 34982866 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure (PE) therapy for PTSD
Number of subjects: 4
Study 34675477 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant 0.7 mg (DEX) every 5 months
Number of subjects: 284
Study 34675477 — intervention group
Group type: COMPARATOR
Intervention: Laser photocoagulation every 3 months as needed
Number of subjects: 284
Study 34924506 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofol
Number of subjects: 39
Study 34924506 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 39
Study 33314313 — intervention group
Group type: EXPERIMENTAL
Intervention: Active vibration therapy (30 Hz and 0.3 g)
Number of subjects: 80
Study 33314313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 34814113 — intervention group
Group type: EXPERIMENTAL
Intervention: DEC (fast start followed by decreasing speed)
Number of subjects: 10
Study 34814113 — intervention group
Group type: EXPERIMENTAL
Intervention: VAR (systematic variation in exercise intensity)
Number of subjects: 10
Study 34814113 — intervention group
Group type: COMPARATOR
Intervention: CON (constant speed)
Number of subjects: 10
Study 34814113 — intervention group
Group type: EXPERIMENTAL
Intervention: DEC and VAR
Number of subjects: 10
Study 34814113 — intervention group
Group type: COMPARATOR
Intervention: DEC, VAR, and CON
Number of subjects: 10
Study 32246224 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS-114/S-1 (TAS-114 400 mg and S-1 30 mg/m2)
Number of subjects: 127
Study 32246224 — intervention group
Group type: COMPARATOR
Intervention: S-1 (S-1 30 mg/m2)
Number of subjects: 127
Study 33579655 — intervention group
Group type: EXPERIMENTAL
Intervention: Video laryngoscope
Number of subjects: 70
Study 33579655 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 70
Study 32396409 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag squeeze (group A)
Number of subjects: 190
Study 32396409 — intervention group
Group type: COMPARATOR
Intervention: Sham bag squeeze (group B)
Number of subjects: 190
Study 34619143 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI with PWI
Number of subjects: 338
Study 34619143 — intervention group
Group type: COMPARATOR
Intervention: PVI alone
Number of subjects: 338
Study 34499157 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week exercise program combined with active PBMT (n=45)
Number of subjects: 90
Study 34499157 — intervention group
Group type: COMPARATOR
Intervention: 6-week exercise program combined with placebo PBMT (n=45)
Number of subjects: 90
Study 35057755 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-assisted motivational counselling at the participant's home and two follow-up telephone sessions
Number of subjects: 254
Study 35057755 — intervention group
Group type: COMPARATOR
Intervention: Postal general health information
Number of subjects: 254
Study 35057755 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-assisted motivational counselling
Number of subjects: 254
Study 34222044 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-L vaccine
Number of subjects: 120
Study 34222044 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-I vaccine
Number of subjects: 120
Study 32282927 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) performed by trained general interventional radiologists
Number of subjects: 235